Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NJ Top Docs Approved IVF New Jersey’s ART Laboratory Is the Proud Recipient of the COLA Laboratory Excellence Award
  • USA - English


News provided by

NJ Top Docs

Jun 20, 2014, 12:00 ET

Share this article

Share toX

Share this article

Share toX


Somerset, NJ (PRWEB) June 20, 2014 -- IVF New Jersey’s ART laboratory is the proud recipient of the COLA Laboratory Excellence Award.

In addition to being compliant with all essential and required criteria for Laboratory Accreditation by COLA, IVF New Jersey’s ART Laboratory has been recognized for a perfect on-site inspection and proficiency testing performance history.

Accreditation is given only to laboratories that apply rigid standards of quality in day-to-day operations, demonstrate continued accuracy in the performance of proficiency testing and pass a rigorous on-site laboratory survey.

IVF New Jersey is one of the only larger, successful fertility centers that focuses on providing patients with the individual care and attention that helps to make treatment less stressful and ultimately more productive.

Post this

IVF New Jersey’s ART Laboratory has earned COLA accreditation and the Laboratory Excellence Award as a result of long-term commitment to provide quality service to its patients. This is the fourth award the practice has received since 2006.

COLA is a national healthcare accreditation and nonprofit, physician-directed organization promoting quality and excellence in medicine and patient care. COLA is approved by the federal government, CLIA and sponsored by the American Medical Association.

Dr. Susan L. Treiser, NJ Top Doc, is a Board Certified Reproductive Endocrinologist, and is co-founder and co-director of IVF New Jersey. Dr. Treiser also serves as director of the IVF New Jersey laboratories.

A native of Canada, Dr. Treiser attended Georgetown University School of Medicine in Washington, D.C., where she obtained both a Ph.D. in pharmacology and her medical degree. Following medical school, Dr. Treiser completed her residency in obstetrics and gynecology at Robert Wood Johnson Medical School in New Brunswick, NJ, and was awarded a fellowship in reproductive endocrinology at Columbia University College of Physician and Surgeons in New York City. At Columbia, Dr. Treiser excelled in her field. She was awarded a faculty appointment as clinical assistant in obstetrics and gynecology and helped hundreds of patients achieve their dream of parenthood through the university’s in vitro fertilization (IVF) program.

Despite her success, Dr. Treiser was confident that she could make infertility treatment more individualized and compassionate outside the university atmosphere. Teaming up with her colleague, Dr. Michael Darder, she left Columbia to establish an advanced practice of fertility specialists – IVF New Jersey – that would rival the success of large university-based programs.

When Dr. Treiser and Dr. Michael Darder founded IVF New Jersey in 1990, their goal was to create an infertility practice that combined the best of big-city medicine with the personalized care of a private setting. Today, IVF New Jersey is one of the largest and most successful facilities in the United States, and it continues to be at the forefront of in vitro fertilization and egg donor/donation technology, offering the latest in reproductive care in a warm and compassionate environment.

Dr. Treiser commented, “IVF New Jersey is one of the only larger, successful fertility centers that focuses on providing patients with the individual care and attention that helps to make treatment less stressful and ultimately more productive. Patients are comfortable at IVF New Jersey. Doctors communicate with them directly. Every patient has their own nurse throughout the course of their treatment. Our front desk staff knows every patient by name. We provide an environment that’s unmatched and patients have better experiences here.”

Dr. Treiser is known for her caring, competent approach to reproductive care. Under her supervision, the IVF New Jersey embryology laboratory has repeatedly achieved “Accreditation with Distinction.” She is the author of A Woman Doctor’s Guide to Infertility and has been published in Science magazine. In 2000, Dr. Treiser was the only medical speaker at the International Seminar of Reproductive Ethics, a yearly symposium held at Princeton University. In that same year, together ith Dr. Darder, she received the 2000 Zenith Award from the New Jersey chapter of RESOLVE, a national infertility support group. Dr. Treiser was instrumental in establishing the egg freezing program at IVF New Jersey in 2005.

With facilities in Somerset, Freehold, Hamilton, Short Hills, Flemington and New York City, IVF New Jersey Fertility and Gynecology Center is the largest fertility center specializing in egg donation and in vitro fertilization in New Jersey –and one of the largest in the nation. They offer state-of-the-art facilities and provide services in all areas of fertility testing and diagnosis and treatment, including in vitro fertilization, egg donation, preimplantation genetic diagnosis (PGD), assisted hatching, blastocyst transfer, embryo freezing, intracytoplasmic sperm injection (ICSI), and gestational surrogacy. They also perform hysterosalpingograms (HSG) procedures that detect abnormalities such as scar tissue, polyps, and fibroids in the uterine cavity and congenital defects of the uterus. At IVF New Jersey, they perform the hysterosaplingograms on site with a machine that creates digital movies of the procedure. By using these digital movies, they can open blocked tubes without the use of surgery.

They also offer early pregnancy classes and acupuncture – which increases blood flow to the uterus and ovaries and reduces stress. They serve Bucks County, PA, New Jersey, New York City and international patients, with a high success rate of making their patients’ dreams come true.

Dr. Treiser and the team at IVF New Jersey offer many procedures and services, including:
In Vitro Fertilization (IVF)
Blastocyst Transfer
Assisted Hatching (AHA)
Intracystoplasmic Sperm Injection (ICSI)
Embryo Cryopreservation
Embryo Donation
Egg Freezing
Egg Donor Sharing
Fertility Preservation
Family Balancing
Egg Donation
Gestational Surrogacy
Preimplantation Genetic Diagnosis (PGD)
Polycystic Ovarian Syndrome (PCOS)
Recurrent Pregnancy Loss
Single and Gay (LGBT)
Fertility Medications/IUI
Patients from Distant Places
Surgical Procedures
Sperm Donation
On-site Testing and Diagnosis
Infertility Counseling
Acupuncture Treatment
Psychological Counseling
Concierge Service

Dr.Treiser is conveniently located in Somerset, NJ. For more information and locations you can visit Dr. Treiser’s full profile at http://www.njtopdocs.com/IVFNewJerseySomerset.

About Us
NJ Top Docs is a comprehensive information resource of Top Doctors, Dentists and Hospitals. We are profiling over 900 Healthcare Providers and have made it convenient for you to find them.

NJ Top Docs allows patients to “meet” these providers online before making their appointment.

For more information visit http://www.NJTopDocs.com. You can also follow us on Facebook – Twitter – YouTube

Cristina Mendez, NJ Top Docs, http://www.NJTopDocs.com, +1 908-288-7240 Ext: 100, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.